FRIULCHEMFRIULCHEMFRIULCHEM

FRIULCHEM

No trades
See on Supercharts

FCM fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Friulchem SpA engages in the research and development of pharmaceutical products for third party contract development and manufacturing organizations. It operates through the Veterinary and Human business units. The Veterinary business unit focuses on the processing of active pharmaceutical ingredients such as granules and powders to produce semi-finished and finished antibiotics. The Human unit specializes in the provides generic drug equivalent solutions to licensees. The company was founded by Alessandro Mazzola on January 22, 1996 and is headquartered in Milan, Italy.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

FCM does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company